| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |